Former Biogen CEO Michel Vounatsos Joins Quris-AI Board Former Biogen CEO Michel Vounatsos Joins Quris-AI Board; Yossi Ben Amram Appointed President as BioAI Innovator Continues to Expand

Quris-AI Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023 BOSTON and TEL-AVIV, Israel, March 02, 2023 (GLOBE NEWSWIRE) -- Quris-AI, has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This year’s...

Quris-AI and MBZUAI to launch world-class Bio-AI center in Abu-Dhabi ABU DHABI, United Arab Emirates, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Quris-AI and Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) signed an agreement during Abu Dhabi Sustainability...

Quris Earns Additional Seed Investment Led by SoftBank Vision Fund 2 BOSTON and TEL-AVIV, Israel, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has secured an additional $9...

Merck KGaA, Darmstadt, Germany, Enters into Option Agreement with Quris on its BioAI Platform for Clinical Safety Prediction BOSTON and TEL-AVIV, Israel, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Quris, an artificial intelligence (AI) innovator disrupting the pharmaceutical arena, today announced it has signed an agreement with...